Esteban Ribera
- Virology top 0.2%
- HIV Research and Treatment 90
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 110
- HIV/AIDS Research and Interventions 59
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments 40
- Epidemiology top 1%
- Pneumocystis jirovecii pneumonia detection and treatment 41
- Cytomegalovirus and herpesvirus research 13
- Hepatology top 2%
- Hepatitis C virus research 14
-
- Research on Leishmaniasis Studies 13
- Co-authors
- I OcañaVicenç FalcóAlbert PahissaAdrián CurranPeré DomingoJ M Martínez-VázquezManuel CrespoDaniel Podzamczer
- Journals
- Journal of Antimicrobial Chemotherapy (19 papers)AIDS (14 papers)Clinical Infectious Diseases (11 papers)
- Partner nations
- SpainUnited StatesPalestinian Territory
In The Last Decade
Esteban Ribera
227 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 116
- Virology 1.7k
- Infectious Diseases 3.0k
- Emergency Medicine 1.0k
- Epidemiology 2.3k
- Hepatology 484
Countries citing papers authored by Esteban Ribera
This map shows the geographic impact of Esteban Ribera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esteban Ribera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esteban Ribera more than expected).
Fields of papers citing papers by Esteban Ribera
This network shows the impact of papers produced by Esteban Ribera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esteban Ribera. The network helps show where Esteban Ribera may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esteban Ribera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2020 | 5 | |
| 4 | 2018 | 7 | |
| 5 | 2015 | 96 | |
| 6 | 2014 | 6 | |
| 7 | 2013 | 9 | |
| 8 | 2010 | 16 | |
| 9 | 2009 | 17 | |
| 10 | 2009 | 11 | |
| 11 | 2008 | 4 | |
| 12 | 2006 | 28 | |
| 13 | 2006 | 21 | |
| 14 | 2005 | 101 | |
| 15 | 2004 | 14 | |
| 16 | 2003 | 55 | |
| 17 | 2000 | 1 | |
| 18 | 1991 | 33 | |
| 19 | 1988 | 86 | |
| 20 | 1986 | 64 |
About Esteban Ribera
Esteban Ribera is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Hepatology, having authored 231 papers that have together received 5.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (110 papers), HIV Research and Treatment (90 papers), HIV/AIDS Research and Interventions (59 papers), Pneumocystis jirovecii pneumonia detection and treatment (41 papers), HIV-related health complications and treatments (40 papers), Hepatitis C virus research (14 papers), Cytomegalovirus and herpesvirus research (13 papers) and Research on Leishmaniasis Studies (13 papers). The work is most often cited by research in Virology (1.7k citations), Infectious Diseases (3.0k citations), Emergency Medicine (1.0k citations), Epidemiology (2.3k citations) and Hepatology (484 citations). Esteban Ribera has collaborated with scholars based in Spain, United States and Palestinian Territory. Frequent co-authors include I Ocaña, Vicenç Falcó, Albert Pahissa, Adrián Curran, Peré Domingo, J M Martínez-Vázquez, Manuel Crespo, Daniel Podzamczer, Carlos Bardají Pascual and Estebán Martínez. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, AIDS, Clinical Infectious Diseases, Journal of the International AIDS Society and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.